Depletion of CD34+ and KDR+ EPCs is an independent predictor of early subclinical atherosclerosis in healthy subjects and may provide additional information beyond the classic risk factors and inflammatory markers [62]. This evidence concerns the gene CD34 and atherosclerosis.